Though the inhibition of GSK3β (increase in p-GSK3β-ser9) is a common feature seen in many cancers, inhibiting GSK3β activity can also be tumor-suppressive and can reduce the migration and invasion of cancers [72–74]. This evidence concerns the gene GSK3B and neoplasm.